Related Experiment Video
Updated: Jul 1, 2025

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Usability and Feasibility of the Antipsychotic Medication Decision Aid in a Community Program for First-Episode
Yaara Zisman-Ilani1, Morgan Parker1, Elizabeth C Thomas1
1Department of Social and Behavioral Sciences, College of Public Health, Temple University, Philadelphia (Zisman-Ilani, Thomas); Department of Clinical, Educational, and Health Psychology, Division of Psychology and Language Sciences, University College London, London (Zisman-Ilani); New York State Psychiatric Institute, New York City (Parker, Nossel, Dixon); Institute on Disabilities, College of Education and Human Development, Temple University, Philadelphia (Suarez); Psychosis Education, Assessment, Care and Empowerment, Pennsylvania Early Intervention Center, Philadelphia (Hurford, Bowen); Pennsylvania Early Intervention Center/HeadsUp and Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Calkins); Pat Deegan, Ph.D. & Associates, L.L.C., Byfield, Massachusetts (Deegan); Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York City (Nossel, Dixon).
Objective:
Although antipsychotic medications are considered first-line treatment for psychosis, rates of discontinuation and nonadherence are high, and debate persists about their use. This pilot study aimed to explore the usability, feasibility, and potential impact of a shared decision making (SDM) intervention, the Antipsychotic Medication Decision Aid (APM-DA), for decisions about use of antipsychotic medications.
Methods:
A pilot randomized controlled trial was conducted with 17 participants in a first-episode psychosis program. Nine participants received the APM-DA, and eight received usual care.
Results:
After their appointments, intervention group participants had less decisional conflict and greater satisfaction with decisions than control group participants had. Use of the APM-DA did not increase appointment length. Comparison of the intervention outcomes with the control outcomes was limited because of the small sample.
Conclusions:
The results support the feasibility and usability of an SDM process via the use of the APM-DA in routine community psychosis care.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Community Based Intervention
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Antipsychotic Drugs: Typical and Atypical Agents

